Crossmark

Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

Crossref DOI link: https://doi.org/10.1038/s41591-018-0199-z

Published Online: 2018-10-08

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiang, Lei

Berraondo, Pedro https://orcid.org/0000-0001-7410-1865
Jericó, Daniel

Guey, Lin T.

Sampedro, Ana

Frassetto, Andrea

Benenato, Kerry E.

Burke, Kristine

Santamaría, Eva

Alegre, Manuel

Pejenaute, Álvaro

Kalariya, Mayur

Butcher, William

Park, Ji-Sun

Zhu, Xuling

Sabnis, Staci

Kumarasinghe, E. Sathyajith

Salerno, Timothy

Kenney, Matthew

Lukacs, Christine M.

Ávila, Matías A.

Martini, Paolo G. V.

Fontanellas, Antonio
License Information

Text and Data Mining valid from 2018-10-08
More Information

Article History

Received: 21 March 2018

Accepted: 10 August 2018

First Online: 8 October 2018

Competing interests

: L.J., L.T.G., A.Fr., K.E.B., K.B., M.Ka., W.B., J.-S.P., X.Z., S.S., E.S.K., T.S., M.Ke., C.M.L. and P.G.V.M. are employees of Moderna Therapeutics, Inc. focusing on the development of therapeutic approaches for rare diseases. The other authors declare no competing interests.